122 related articles for article (PubMed ID: 7870663)
1. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: a common transport system of H1-antagonists and lipophilic basic drugs.
Yamazaki M; Terasaki T; Yoshioka K; Nagata O; Kato H; Ito Y; Tsuji A
Pharm Res; 1994 Nov; 11(11):1516-8. PubMed ID: 7870663
[TBL] [Abstract][Full Text] [Related]
2. Carrier-mediated transport of H1-antagonist at the blood-brain barrier: mepyramine uptake into bovine brain capillary endothelial cells in primary monolayer cultures.
Yamazaki M; Terasaki T; Yoshioka K; Nagata O; Kato H; Ito Y; Tsuji A
Pharm Res; 1994 Jul; 11(7):975-8. PubMed ID: 7937557
[TBL] [Abstract][Full Text] [Related]
3. Transport mechanism of an H1-antagonist at the blood-brain barrier: transport mechanism of mepyramine using the carotid injection technique.
Yamazaki M; Fukuoka H; Nagata O; Kato H; Ito Y; Terasaki T; Tsuji A
Biol Pharm Bull; 1994 May; 17(5):676-9. PubMed ID: 7920432
[TBL] [Abstract][Full Text] [Related]
4. Influx and efflux transport of H1-antagonist epinastine across the blood-brain barrier.
Ishiguro N; Nozawa T; Tsujihata A; Saito A; Kishimoto W; Yokoyama K; Yotsumoto T; Sakai K; Igarashi T; Tamai I
Drug Metab Dispos; 2004 May; 32(5):519-24. PubMed ID: 15100174
[TBL] [Abstract][Full Text] [Related]
5. Blood-brain barrier transport of H1-antagonist ebastine and its metabolite carebastine.
Tamai I; Kido Y; Yamashita J; Sai Y; Tsuji A
J Drug Target; 2000; 8(6):383-93. PubMed ID: 11328664
[TBL] [Abstract][Full Text] [Related]
6. Involvement of the pyrilamine transporter, a putative organic cation transporter, in blood-brain barrier transport of oxycodone.
Okura T; Hattori A; Takano Y; Sato T; Hammarlund-Udenaes M; Terasaki T; Deguchi Y
Drug Metab Dispos; 2008 Oct; 36(10):2005-13. PubMed ID: 18606742
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of the binding of [3H]-mepyramine to intact human U373 MG astrocytoma cells: evidence for histamine-induced H1-receptor internalisation.
Hishinuma S; Young JM
Br J Pharmacol; 1995 Nov; 116(6):2715-23. PubMed ID: 8590995
[TBL] [Abstract][Full Text] [Related]
8. Investigation on the influx transport mechanism of pentazocine at the blood-brain barrier in rats using the carotid injection technique.
Suzuki T; Moriki Y; Goto H; Tomono K; Hanano M; Watanabe J
Biol Pharm Bull; 2002 Oct; 25(10):1351-5. PubMed ID: 12392093
[TBL] [Abstract][Full Text] [Related]
9. Characterization of histamine H1-receptors on astrocytes in primary culture: [3H]mepyramine binding studies.
Inagaki N; Fukui H; Taguchi Y; Wang NP; Yamatodani A; Wada H
Eur J Pharmacol; 1989 Nov; 173(1):43-51. PubMed ID: 2575040
[TBL] [Abstract][Full Text] [Related]
10. Characterization of thromboxane A2/prostaglandin H2 receptors and histamine H1 receptors in cultured guinea-pig tracheal smooth-muscle cells.
Miki I; Nonaka H; Ishii A
Biochim Biophys Acta; 1992 Oct; 1137(1):107-15. PubMed ID: 1356444
[TBL] [Abstract][Full Text] [Related]
11. Transport of monocarboxylic acids at the blood-brain barrier: studies with monolayers of primary cultured bovine brain capillary endothelial cells.
Terasaki T; Takakuwa S; Moritani S; Tsuji A
J Pharmacol Exp Ther; 1991 Sep; 258(3):932-7. PubMed ID: 1890627
[TBL] [Abstract][Full Text] [Related]
12. P-glycoprotein as the drug efflux pump in primary cultured bovine brain capillary endothelial cells.
Tsuji A; Terasaki T; Takabatake Y; Tenda Y; Tamai I; Yamashima T; Moritani S; Tsuruo T; Yamashita J
Life Sci; 1992; 51(18):1427-37. PubMed ID: 1357522
[TBL] [Abstract][Full Text] [Related]
13. Modulation of antagonist binding to histamine H1-receptors by sodium ions and by 2-amino-2-hydroxymethyl-propan-1,3-diol HCl.
Gibson WJ; Roques TW; Young JM
Br J Pharmacol; 1994 Apr; 111(4):1262-8. PubMed ID: 7913374
[TBL] [Abstract][Full Text] [Related]
14. High affinity, saturable [3H]mepyramine binding sites on rat liver plasma membrane do not represent histamine H1-receptors. A warning.
Leurs R; Bast A; Timmerman H
Biochem Pharmacol; 1989 Jul; 38(13):2175-80. PubMed ID: 2567596
[TBL] [Abstract][Full Text] [Related]
15. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier.
Tsuji A; Saheki A; Tamai I; Terasaki T
J Pharmacol Exp Ther; 1993 Dec; 267(3):1085-90. PubMed ID: 8263769
[TBL] [Abstract][Full Text] [Related]
16. Is there a difference in the affinity of histamine H1 receptor antagonists for CNS and peripheral receptors? An in vitro study.
Ter Laak AM; Donné-Op den Kelder GM; Bast A; Timmerman H
Eur J Pharmacol; 1993 Mar; 232(2-3):199-205. PubMed ID: 8096817
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of histamine H1- and H2-receptors in guinea-pig left atrial membranes by [3H]-mepyramine and [3H]-tiotidine binding.
Hattori Y; Endou M; Gando S; Kanno M
Br J Pharmacol; 1991 Jun; 103(2):1573-9. PubMed ID: 1909203
[TBL] [Abstract][Full Text] [Related]
18. Affinities of histamine H1-antagonists in guinea pig brain: similarity of values determined from [3H]mepyramine binding and from inhibition of a functional response.
Hill SJ; Daum P; Young JM
J Neurochem; 1981 Nov; 37(5):1357-60. PubMed ID: 6117608
[TBL] [Abstract][Full Text] [Related]
19. Molecular properties of central and peripheral histamine H1 and H2 receptors.
Carman-Krzan M; Lipnik-Stangelj M
Pflugers Arch; 2000; 439(3 Suppl):R131-2. PubMed ID: 10653166
[TBL] [Abstract][Full Text] [Related]
20. Does the [3H]mepyramine binding site represent the histamine H1 receptor? Re-examination of the histamine H1 receptor with quinine.
Liu Q; Horio Y; Fujimoto K; Fukui H
J Pharmacol Exp Ther; 1994 Feb; 268(2):959-64. PubMed ID: 8114011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
